title: Profile of the MP Diagnostics HTLV Blot 2.4 test: a supplemental assay for the confirmation and differentiation of antibodies to HTLV-1 and HTLV-2.
abstract: As the first US FDA-approved assay for supplemental HTLV testing, the MP Diagnostics HTLV Blot 2.4 is an effective and efficient method for confirming and differentiating HTLV type infection in repeatedly reactive samples. Novel and patented antigens added increased sensitivity in identifying specimens from infected individuals while differentiating those from uninfected individuals with false reactivity.
authors.affiliation: a Clinical Research & Regulatory Affairs , MP Biomedicals , Santa Ana , CA , USA.
authors.forename: Liane
authors.initials: L
authors.lastname: Miller
mesh_terms: D015481:HTLV-I Antibodies / Q000097:blood* / Q000276:immunology; D015482:HTLV-II Antibodies / Q000097:blood* / Q000276:immunology; D015368:Human T-lymphotropic virus 1 / Q000276:immunology*; D015367:Human T-lymphotropic virus 2 / Q000276:immunology*; D006801:Humans; D011933:Reagent Kits, Diagnostic / Q000592:standards*; D012680:Sensitivity and Specificity; D012698:Serologic Tests / Q000379:methods*
chemical_list: D015481:HTLV-I Antibodies; D015482:HTLV-II Antibodies; D011933:Reagent Kits, Diagnostic
keywords: HTLV; HTLV-I; HTLV-II; blood donor; confirmatory; laboratory; viral type